drugset / Trial / NCT03248297

Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries

NCT03248297 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study, performed over a course of 3 years in 5 collaborating hospitals in Cameroon, Africa, will randomize 750 women in labor with prolonged rupture of membranes ≥ 8 hours or prolonged labor ≥ 18 hours to identical oral regimens of 1 gram of azithromycin, 1 gram of azithromycin+2 grams of amoxicillin or placebo. Women will be followed to ascertain maternal infectious outcomes and perinatal outcomes.

Timeline

Start
2018-01-12
Primary completion
2020-05-15
Completion
2020-10-01

Outcome

Missed primary endpoint

paper Composite outcome incidences were similar in antibiotic groups 1 (6%) and 2 (7%) compared with placebo group 3 (10%) PMID 34619734 ↗

paper did not reduce maternal peripartum or neonatal infection. PMID 34619734 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 2 g Oral
Subject Azithromycin Small molecule 1 g Oral